¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gender, technology and development."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® development ÇÑ±Û ¹ß´Þ, ¹ß»ý, ¹ßÀ°
¼³¸í   
  1. ¹ß´Þ. ½É½ÅÀÇ ÇüÅ¿͠Àç´ÉÀÇ »ó½ÂÀûÀΠº¯È­°úÁ¤. ¼ºÀå°ú ¸Å¿ì À¯»çÇÑ °³³äÀ¸·Î, ¶§·Î´Â °°Àº ¶æÀ¸·Î ¾²À̴ °æ¿ìµµ ÀÖ´Ù. ±×·¯³ª ¼ºÀåÀº °³Ã¼ÀÇ ¹ßÀ°¿¡ µû¸£´Â º¯È­, Áï °è¿­ÀûÀ¸·Î ¾çÀûÀΠÁõ°¡·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ¸¹ÀÌ ¾²À̰í, ¹ß´ÞÀº À̿͠°°Àº º¯È­¸¦ ¾çÀûÀΠ¸é»Ó¸¸ ¾Æ´Ï¶ó, ±¸Á¶³ª Àç´ÉÀÌ ºÐÈ­-º¹ÀâÈ­-Á¤¹ÐÈ­-À¯´ÉÈ­-ÅëÇÕÈ­µÇ¾î °¡´Â °ÍÀ¸·Î¼­ ±â¼úÇϴ °æ¿ì¿¡ ´õ¿í ¸¹ÀÌ ¾²À̴ °æÇâÀÌ ÀÖ´Ù. ±×¸®°í ¹ß´ÞÀ̶ó°í Çϴ °³³äÀº, À¯±âüÀÇ ¹ßÀ°¿¡ ´ëÇØ¼­¸¸ ¾²À̴ °ÍÀÌ ¾Æ´Ï¶ó, ¹«»ý¹°À̳ª ¹°¸®Àû-È­ÇÐÀû Çö»ó¿¡ ´ëÇØ¼­µµ ¶Ç´Â »çȸÀû-¹®È­Àû Çö»ó¿¡ ´ëÇØ¼­µµ ½Ã°£Àû º¯È­¹ßÀüÀ» ¼ö¹ÝÇϴ °æ¿ì¿¡ Àû¿ëµÇ´Â °³³äÀÌ´Ù. 2. ¹ßÀ°. ¹ßÀ°°úÁ¤¿¡´Â ´ÙÀ½°ú °°Àº ÀϹÝÀûÀΠ¿øÄ¢À» º¸ÀδÙ. ¨ç ¹ßÀ°Àº Áú¼­Á¤¿¬ÇϰԠÀÏÁ¤ÇÑ ¼ø¼­¸¦ °®´Â´Ù. ¨è ¹ßÀ°Àº ¿¬¼ÓÀûÀ̳ª ÀÏÁ¤ÇÑ ¼Óµµ·Î ÁøÇàÇϴ °ÍÀº ¾Æ´Ï´Ù. ¨é ¹ßÀ°¿¡´Â ¹ßÀ°»ó Áß¿äÇÑ °¨¼ö±â¿Í ÀÓ°è±â°¡ ÀÖ´Ù.
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gender
    1. ¼º 2. ȹµæ¼º
  • gender identity
    ¼ºÁÖü¼º
  • gender identity disorder
    ¼ºÁ¤Ã¼¼ºÀå¾Ö
  • gender role
    ¼º¿ªÇÒ, ȹµæ¼º¿ªÇÒ
  • assisted reproductive technology
    º¸Á¶»ý½Ä±â¼ú
  • hybridoma technology
    ÇÏÀ̺긮µµ¸¶±â¹ý
  • recombinant DNA technology
    ÀçÁ¶ÇÕDNA±â¼ú
  • reproductive technology
    Àç»ý»ê¼ú
  • technology
    񃬣
  • technology assessment
    ±â¼úÆò°¡
  • cognitive development
    ÀÎÁö¹ß´Þ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤°³¹ß
  • development
    1. Çö»ó 2. Àü°³ 3. ¹ß»ý, ¹ßÀ°, ¹ß´Þ 4. °³¹ß 5. ¹ß»ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
  • gender
    1.¼º, 2.ȹµæ¼º
  • technology assessment
    ±â¼úÆò°¡
  • technology
    񃬣
  • assisted reproductive technology
    º¸Á¶»ý½Ä±â¼ú
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gender
    ¼º
  • gender identity
    ¼ºÁÖü¼º
  • gender role
    ¼º¿ªÇÒ, ȹµæ¼º¿ªÇÒ
  • assisted reproductive technology
    º¸Á¶»ý½Ä±â¼ú
  • hybridoma technology
    ÀâÁ¾¼¼Æ÷Á¾±â¹ý
  • reproductive technology
    Àç»ý»ê¼ú
  • technology
    񃬣
  • arrested development
    Á¤ÁöµÈ¹ß´Þ
  • cognitive development
    ÀÎÁö¹ß´Þ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤ÀÛ¼º, ±³À°°úÁ¤°³¹ß
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
  • development quotient
    ¹ß´ÞÁö¼ö
  • digenetic development
    º¹¼¼´ë¹ßÀ°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • X-ray technology
    X¼± ÃÔ¿µ±â¼ú
  • hybridoma technology
    ÇÏÀ̺긮µµ¸¶<¸²ÇÁÀâÁ¾¼¼Æ÷Á¾>±â¼úÇÐ
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • arrested development
    ¹ß´ÞÁ¤Áö.
  • personality development
    ÀÎ°Ý ¹ß´Þ
  • postnatal development
    »ýÈĹßÀ°(¡­Û¡ëÀ).
  • prenatal development
    Ãâ»ýÀü¹ßÀ°(¡­Û¡ëÀ).
  • primary bone development
    ÀÏÂ÷»À¹ß»ý
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ.
  • psychosocial development
    Á¤½Å»çȸÀû ¹ß´Þ
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
  • Death and dying
    »ç¸Á°úÀÓÁ¾
  • ENT =ear, nose and throat
    À̺ñÀÎÈİú(ÇÐ)
  • General anesthesia, reticular activating system and.
    Àü½Å¸¶Ãë(îïãóئö­), ¸Á»óüȰ¼ºÈ­°è(ØÑßÒô÷üÀàõûùͧ)
  • Gravity, cardiac output and
    Áß·Â(ñìÕô), ½É¹ÚÃâ·®(ãýÚÑõóÕá)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sexual and gender identity disorders
    ¼º ¹× Á¤½Å¼ºÀû ÁÖü¼ºÀå¾Ö(º´)
  • assisted reproductive technology
    º¸Á¶»ý½Ä¼ú
  • dental technology
    Ä¡°úÀ̰øÇÐ(¡­ìµÍïùÊ).
  • hybridoma technology
    ÇÏÀ̺긮µµ¸¶<¸²ÇÁÀâÁ¾¼¼Æ÷Á¾>±â¼úÇÐ
  • reproductive technology
    Àç»ý»ê(±â-)¼ú
  • splint technology
    ºÎ¸ñ ±â¼ú.
  • x-ray technology
    X¼± ±â¼ú
  • core gender identity
    ÇÙ½ÉÀû Á¤½Å¼º ÁÖü¼º(ú·ãýîÜïñãêàõñ«ô÷àõ)
  • gender
    ¼º
  • gender
    ȹµæ¼º, ¼º
  • gender assignment
    ¼º(Àû) ºÎ¿©
  • gender identity
    ¼º(Àû)µ¿Àϼº
  • gender identity disorder
    (ȹµæ)¼ºÁÖü¼º Àå¾Ö(º´)(üòÔðàõñ«ô÷àõî¡äô)
  • gender reassignment
    ¼º(Àû) ÀçºÎ¿©
  • gender role
    ¼ºÀû¿ªÇÒ(àõîÜæµùÜ), ³²³à¿ªÇÒ(ÑûåüæµùÜ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Membranous bone development
    ¸·»À¹ß»ý
    [¿¾ ¿ë¾î] ¸·¼º°ñ¹ß»ý
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • continuous development
    ¿¬¼ÓÀü°³(ææáÙî÷ËÒ)
  • displacement development
    ´ëÄ¡Àü°³(ÓÛöÇî÷ËÒ) (ÔÒ) displacement chromatography
  • stepwise development
    ´Ü°èÀû Àü°³(Ó«Í­îÜî÷ËÒ)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
  • Lavoisier and Laplace law
    ¶óº¸¾ÆÁ¦ ¶óÇÁ¶óÀ̽º¹ýÄ¢(ÛööÎ)
  • lock and key theory
    ÀÚ¹°¼è-¿­¼èÀÌ·Ð(ìµÖå)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • "Monod, Wyman, and Changeux model"
    ¸ð³ë.¿ÍÀ̸¸.¼§Á¶¸ðµ¨
  • Park and Johnson method
    ÆÄÅ© Á¸½¼ ¹ý(Ûö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, ¡ìÇʸ§ÀÇ¡íÇö»ó
  • medical technology
    ÀÇ·á°Ë»ç¹ý
  • technology
    ±â¼úÇÐ, °ø¿¹ÇÐ
  • X-ray technology
    X¼± ÃÔ¿µ±â¼ú
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • PACS [=picture archiving and communicating system]
    ÆÑ½º, ¿µ»óÀúÀå ¹× Àü¼Ûü°è
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • R & F [=radiography and fluoroscopy]
    ¹æ»ç¼±ÃÔ¿µ ¹× Åõ½Ã±â
  • salt and pepper appearance
    ¼Ò±ÝÈÄÃß°¡·ç¸ð¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CHARGE coloboma, heart disease, atresia choanae, retarded growth and retarded development and/or CNS anomal...
GIDAANT Gender Identity Disorder of Adolescence or Adulthood, Non-transsexual Type
GBD gallbladder disease; gender behavior disorder; glass blower's disease; granulomatous bowel disease
GEN gender; generation
GID gender identity disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NIST National Institute of Standards and Technology
HUD Housing and Urban Development
MGDF Megakaryocyte Growth and Development Factor
NICHD National Institute of Child Health and Human Development
OECD Organisation for Economic Co-operation and Development
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 29862
    JournalTitle: Gender, technology and development.
    MedAbbr: Gend Technol Dev
    ISSN: 0971-8524
    ESSN:
    IsoAbbr:
    NlmId: 9891661
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • development of speech and language
    ÀÇ»ç ¼ÒÅëÀÇ ¹ß´Þ
  • dental technology
    Ä¡°ú À̰øÇÐ
  • technology
    ±â¼úÇÐ, °ø¿¹ÇÐ, ±â¼ú
    °úÇÐÀû Áö½Ä, ±â¼ú ¿¬±¸ÀÇ Áý¼º.
  • child development
    ¼Ò¾Æ ¹ß´Þ
  • cognitive development
    ÀÎÁöÀû ¹ß´Þ
  • development
    ¹ß»ý, ¹ßÀ°, Àü°³, Çö»ó
    1. ¹ß´Þ, ¹ß»ý, ¹ßÀ°, Çö»ó. ¹ßÀ°°ú ºÐÈ­ÀÇ °úÁ¤. 2. Çö»ö, Àü°³. 3. ³ë±¤¿¡ ÀÇÇØ °¨±¤¸·ÀÇ À¯Á¦¸· ¼Ó¿¡ »ý±ä Àá»óÀ» °¡½ÃÀÇ »óÀ¸·Î ¸¸µå´Â ÀÏ. ÃÔ¿µÀÌ ³¡³­ Çʸ§¿¡´Â ´«¿¡ º¸ÀÌÁö ¾ÊÀ¸³ª Àá»óÀ̶ó´Â ÇÇ»çü°¡ ±â·ÏµÇ¾î ÀÖ´Ù. ÀÌ¿Í °°ÀÌ ±â·ÏµÈ ´«¿¡ º¸ÀÌÁö ¾Ê´Â Çʸ§À» ¾Ï½Ç¿¡¼­ Çö»ó¾×À̶ó´Â ¾àǰ¿¡ ÀÏÁ¤½Ã°£ ´ã°¡µÎ¸é ´«¿¡ º¸ÀÌÁö ¾Ê´ø ±â·Ï È­»ó
  • development disorder
    ¹ßÀ° Àå¾Ö
  • ectopoc development
    ÀÌ¼Ò ¹ßÀ°
  • embryonic development
    ¹è ¹ß»ý
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • incomplete development
    ºÒ¿ÏÀüÇÑ ¹ßÀ°
  • personality development
    ¼º°Ý ¹ß´Þ
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ
  • sensory development
    °¨°¢ ¹ß´Þ, Áö°¢ ¹ß´Þ
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
sexual and gender disorders Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders.
(12 Dec 1998)
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
state health planning and development agencies Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council.
(12 Dec 1998)
land conservation and development commission (LCDC) A commission appointed to determine land use policy in Oregon.
(05 Dec 1998)
gender 1. Kind; sort. "One gender of herbs."
2. Sex, male or female.
3. A classification of nouns, primarily according to sex; and secondarily according to some fancied or imputed quality associated with sex. "Gender is a grammatical distinction and applies to words only. Sex is natural distinction and applies to living objects." (R. Morris)
Adjectives and pronouns are said to vary in gender when the form is varied according to the gender of the words to which they refer.
Origin: OF. Genre, gendre (with excrescent d), F.genre, fr. L. Genus, generis, birth, descent, race, kind, gender, fr. The root of genere, gignere, to beget, in pass, to be born, akin to E. Kin. See Kin, and cf. Generate, Genre, Gentle, Genus.
Source: Websters Dictionary
(01 Mar 1998)
gender dysphoria syndrome <syndrome> A syndrome in which an individual experiences marked personal stress due to feelings that despite having the genitalia and secondary sexual characteristics of one gender there is a sense of compatibility and greater belonging to the other gender class; one may undergo surgery to reconstruct anatomy to that of the other gender.
(05 Mar 2000)
gender identity A person's concept of himself as being male and masculine or female and feminine, or ambivalent, usually based on the physical characteristics, parental attitudes and expectations, and psychological and social pressures to which the individual is subjected. It is the private experience of gender role.
(12 Dec 1998)
gender identity disorders A class of mental disorders characterised by an incongruity between an assigned culturally determined set of attitudes, behaviour patterns, and physical characteristics associated with masculinity or femininity and gender identity.
See: transsexualism.
(05 Mar 2000)
gender role The sex of a child assigned by a parent; when opposite to the child's anatomical sex (e.g., due to genital ambiguity at birth or to the parents' strong wish for a child of the opposite sex), the basis is set for postpubertal dysfunctions.
See: sex role, sex reversal.
(05 Mar 2000)
antibody technology <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics.
(09 Feb 1998)
assisted reproductive technology Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos.
The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions.
See: eugenics.
(05 Mar 2000)
recombinant DNA technology A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome.
(12 Dec 1998)
national centre for health care technology A centre in the public health service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology.
(12 Dec 1998)
DNA technology, recombinant A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome.
(12 Dec 1998)
technology <study> Industrial science; the science of systematic knowledge of the industrial arts, especially of the more important manufactures, as spinning, weaving, metallurgy, etc.
Technology is not an independent science, having a set of doctrines of its own, but consists of applications of the principles established in the various physical sciences (chemistry, mechanics, mineralogy, etc) to manufacturing processes.
Origin: Gr. An art; cf. Gr. Systematic treatment: cf. F. Technologie.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • International Bank for Reconstruction and Development
    ±¹Á¦ ºÎÈï°³¹ßÀºÇà(IBRD)ÅëĪ(the world bank)
  • research and development
    ¿¬±¸¿Í °³¹ß
  • gender
    ¼ºº°
  • common gender
    Å뼺(³²³à ¾ç¼º¿¡ ÅëÇÏ´Â `parent'µî)
  • gender
    ¼º
  • gender gap
    ¼ºº° ÁöÁöÀ²ÀÇ °ÝÂ÷(¼±°Å¿¡¼­ Èĺ¸¿¡ ´ëÇÑ ³²¼º°ú ¿©¼ºÀÇ ÁöÁöÀ²ÀÇ Â÷ÀÌ)
  • grammatical gender
    ¹®¹ý»óÀÇ ¼º
  • masculine gender
    ³²¼º
  • technology
    °úÇбâ¼ú,°ø¿¹ÇÐ
  • Massachusetts Institute of Technology
    ¸Å»çÃß¼¼Ã÷ °ø°ú ´ëÇÐ(»ç¸³ ´ëÇÐ)
  • educational technology
    ±³À° °øÇÐ
  • high technology
    ÷´Ü ±â¼ú;°íµµ °úÇÐ ±â¼ú;ÇÏÀÌ Å×Å©³î·ÎÁö
  • intermediate technology
    Áß°£ °øÇÐ(¼Ò±Ô¸ðÀûÀÌ°í °£´ÜÇÑ ¹æ¹ýÀ̳ª ±â¼úÀ» Çö´ëÀÇ Ã·´Ü ±â¼úÀ̳ª ±â°è¿¡ °áºÎ½ÃŲ °øÇÐ)
  • marine technology
    ÇØ¾ç °øÇÐ (±â¼ú)
  • psychological technology
    ½É¸®°øÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á